Hormonal factors such as insulin-like growth factor 1 (IGF-1) and leptin have been shown to be decreased by metformin administration [10] and may potentially be responsible for the reduction of the cancer growth-supporting potential of patient sera. This evidence concerns the gene IGF1 and cancer.